Umbralisib in Combination with Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukaemia or Mantle Cell Lymphoma: A Multicentre Phase 1–1b Study

Drug Category: Array
Conference Category: Array
Lead Author: Davids M, et al.
Published Date: 14/12/2018
Download Link: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(18)30196-0/fulltext
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top